… 1993 as the first FDA-approved treatment for multiple sclerosis, the era of treatment of this
incurable … Currently, seven different treatments for patients with multiple sclerosis with different …

… effective in remitting and relapsing multiple sclerosis: II. MRI analysis … acetate in relapsing
multiple sclerosis patients observed for … extension trial for relapsing multiple sclerosis: MRI and …

Although the earliest recorded description of multiple sclerosis (MS) dates back to the 14 th
century, it was not until the latter years of the 20 th that treatments for this disabling condition …

… Multiple sclerosis causes bothersome or disabling physical … Current preventive disease-modifying
therapies (DMTs) for … patients have relapsing-remitting multiple sclerosis (RRMS), in …

… Cell therapy Cell replacement has attracted full attention as a new strategy for the treatment
of multiple sclerosis. The cell-based therapies aim to regulate the immune response to …

… Multiple sclerosis (MS) is a potentially disabling chronic … of many disease-modifying therapies
(DMTs) that prevent … therapies, and drugs that can be considered for off-label use in MS. …

… for multiple sclerosis (fingolimod, natalizumab, dimethyl fumarate, teriflunomide, alemtuzumab)
offer advantages of efficacy or tolerability over the injectable therapies of the 1990s. But …

… disease-modifying therapies (DMTs) are licensed for relapsing multiple sclerosis, including
… multiple sclerosis—Ocrelizumab,6 the first treatment for primary progressive multiple sclerosis…

… multiple sclerosis therapies according to their average relapse reduction. We sought to
classify newer therapies (… Materials & methods: Therapies were classified by using direct …

… therapies for multiple sclerosis (MS) is being advanced. In this article we discuss a selection
of therapies … boundaries between immunosuppressive and immunomodulatory therapies. …